Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02812056
Title Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

vulva cancer

oropharynx cancer

cervical cancer

penile cancer

anus cancer

vaginal cancer


Alisertib + Sapanisertib

Age Groups: adult
Covered Countries

No variant requirements are available.